Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial. (2024)

First Author: Hendrick J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ofid/ofad630

PubMed Identifier: 38312212

Publication URI: http://europepmc.org/abstract/MED/38312212

Type: Journal Article/Review

Volume: 11

Parent Publication: Open forum infectious diseases

Issue: 2

ISSN: 2328-8957